Clinical trial
Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With…
NCT00393939 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00393939 |
|---|---|
| Title | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer |
| Official title | A Randomized Phase 3 Study Of Docetaxel In Combination With Sunitinib Versus Docetaxel In The First-Line Treatment Of Advanced Breast Cancer Patients |
| Acronym | SUN 1064 |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | Sunitinib malate, Taxotere |
| Enrollment | 594 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Jul 1, 2011 |
| First posted | Oct 31, 2006 |
| Last update posted | Jul 19, 2012 |
| Countries | Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, Finland, France, Germany, Hungary, Ireland and 15 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: